patient stratification
Genosity Inks Deal With Gemini Therapeutics to Develop Assay for AMD Clinical Trial Patient Selection
The assay will be used to select patients for enrollment in a Phase IIa study of Gemini Therapeutics' dry age-related macular degeneration drug GEM103.
British bioinformatics firm PrecisionLife has mined the UK Biobank to identify genetic risk factors for late-stage COVID-19 patients developing sepsis.
Novogene, Chipscreen Ink CDx Development Deal
Chipscreen is developing a small molecule inhibitor of key serine-threonine kinases involved in tumor angiogenesis, cell mitosis, and microenvironment inflammation.
Thermo Fisher, Genome Canada Ink C$6M Collaboration on Cancer NGS Assays
The assays will combine genomic and gene expression analyses to better understand driver mutations in prostate, breast, and pancreatic cancers.
Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine
Premium
Experts discussed the benefits and challenges of implementing precision medicine protocols for oncology patients at this week's Tri-Conference meeting